Ramy Farid - Feb 9, 2023 Form 4 Insider Report for Schrodinger, Inc. (SDGR)

Role: President & CEO, Director
Signature: /s/ Donald Shum, as attorney-in-fact for Ramy Farid
Stock symbol: SDGR
Transactions as of: Feb 9, 2023
Transactions value $: $0
Form type: 4
Date filed: 2/10/2023, 04:00 PM
Previous filing: Feb 9, 2023
Next filing: Mar 5, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SDGR	Stock Option (right to buy)	Award	$0	+85K		$0.00	85K	Feb 9, 2023	Common Stock	85K	$23.29	Direct	F1
transaction	SDGR	Stock Option (right to buy)	Award	$0	+65.5K		$0.00	65.5K	Feb 9, 2023	Common Stock	65.5K	$25.62	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option was granted on February 9, 2023. The shares underlying the option are scheduled to vest with respect to 25% of the shares on February 9, 2024 and the remainder are scheduled to vest in equal monthly installments through February 9, 2027.
F2	The option was granted on February 9, 2023. The exercise price per share is equal to 110% of the closing price of the Issuer's common stock on the Nasdaq Global Select Market on the date of grant. The shares underlying the option are scheduled to vest with respect to 25% of the shares on February 9, 2024 and the remainder are scheduled to vest in equal monthly installments through February 9, 2027.

Content

The option was granted on February 9, 2023. The shares underlying the option are scheduled to vest with respect to 25% of the shares on February 9, 2024 and the remainder are scheduled to vest in equal monthly installments through February 9, 2027.

The option was granted on February 9, 2023. The exercise price per share is equal to 110% of the closing price of the Issuer's common stock on the Nasdaq Global Select Market on the date of grant. The shares underlying the option are scheduled to vest with respect to 25% of the shares on February 9, 2024 and the remainder are scheduled to vest in equal monthly installments through February 9, 2027.